✦ LIBER ✦

PEY5 COST-EFFECTIVENESS MODELING OF LUCENTIS VERSUS USUAL CARE IN AGE RELATED MACULAR DEGENERESCENCE

✍ Scribed by A Beresniak; S Cohen; G Quentel; G Mimoun; T Citterio; D Bremond-Gignac

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness sequential modeling o

✍ S. Y. Cohen; D. Bremond-Gignac; G. Quentel; G. Mimoun; T. Citterio; S. Bisot-Loc 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 198 KB

PEY17 COST-EFFECTIVENESS OF PEGAPTANIB I

✍ J Javitt; S Wolowacz; N Roskell; S Maciver; S Kelly; A Pleil; G Zlateva 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PEY3 RANIBIZUMAB (LUCENTIS®) IS A COST-E

✍ AS Neubauer; El Back; T Kuehn; VS Thomas 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PEY5 ECONOMIC EVALUATION OF PHOTODYNAMIC

✍ SJ Barry; PR Douglas; DL Becker; MS Hughes; MC Weinstein 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

PSS15 THE COST-EFFECTIVENESS OF RANIBIZU

✍ A Turpcu; JW Hay 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

Cost-Effectiveness Analysis of Ranibizum

✍ Kostas Athanasakis; Vasilios Fragoulakis; Vasiliki Tsiantou; Panagiotis Masaouti 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 551 KB